Condition (MeSH)
Liver Abscess
ClinicalTrials.gov lists 19 trials for Liver Abscess or a narrower condition beneath it. Bayer has the most among industry and government lead sponsors, with 1.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
13 of the 19 trials are tagged with Liver Abscess itself; the rest are tagged with a narrower condition beneath it.
When did Liver Abscess trials start? (12)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 2 |
| 2025 | 3 |
| 2024 | 3 |
| 2022 | 1 |
| 2021 | 1 |
| 2020 | 1 |
| 2019 | 1 |
| 2016 | 1 |
| 2014 | 1 |
| 2013 | 2 |
Showing 10 of 12 earlier years.
No forecast is made for this condition: it averages 1.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Liver Abscess trials in? (4)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 3 | 3 |
| Phase 4 | 2 |
| Not applicable | 3 |
| Observational | 11 |
How many Liver Abscess trials are recruiting? (4)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 4 |
| Recruiting | 2 |
| Completed | 8 |
| Unknown status | 5 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Liver Abscess trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Bayer | 1 |
Which drugs are being tested for Liver Abscess? (3)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Gadoxetate Disodium | 1 |
| Cefixime | 1 |
| Diloxanide furoate | 1 |
Interventions as named in the registry (8)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Ceftriaxone 4g/ 24h | 2 |
| PO ciprofloxacin | 2 |
| Ertapeneme | 1 |
| C: moxifloxacin | 1 |
| Intravenous beta-lactam antimicrobial for 2 weeks Plus Intravenous Metronidazole (750 mg q 8 hourly) for 2 weeks | 1 |
Showing 5 of 8 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Liver Abscess trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Febrile neutropenia | 7 | 1 |
| Pyrexia | 3 | 1 |
| Abdominal pain | 2 | 1 |
| Rhinovirus infection | 2 | 1 |
| Anaemia | 1 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Liver Abscess? (35)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Efficacy of empirical Ciprofloxacin or Cefixime plus Metronidazole therapy for the treatment of liver abscess: a randomized control clinical trial. | Scientific reports | 2024 | Yes |
| Cost-minimization analysis of oral versus intravenous antibiotic treatment for Klebsiella pneumoniae liver abscess. | Scientific reports | 2023 | Yes |
| Outer membrane vesicles derived from hypervirulent Klebsiella pneumoniae stimulate the inflammatory response. | Microbial pathogenesis | 2021 | Yes |
| Interaction of <i>Klebsiella pneumoniae</i> with tissue macrophages in a mouse infection model and ex-vivo pig organ perfusions: an exploratory investigation. | The Lancet. Microbe | 2021 | Yes |
| Oral vs Intravenous Antibiotics for Patients With Klebsiella pneumoniae Liver Abscess: A Randomized, Controlled Noninferiority Study. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2020 | Yes |
Showing 5 of 35 publications.
Sub-conditions in MeSH (2)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence and rare-disease identity.